132 related articles for article (PubMed ID: 20655890)
1. Evaluating the utility of N1,N12-diacetylspermine and N1,N8-diacetylspermidine in urine as tumor markers for breast and colorectal cancers.
Umemori Y; Ohe Y; Kuribayashi K; Tsuji N; Nishidate T; Kameshima H; Hirata K; Watanabe N
Clin Chim Acta; 2010 Dec; 411(23-24):1894-9. PubMed ID: 20655890
[TBL] [Abstract][Full Text] [Related]
2. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
[TBL] [Abstract][Full Text] [Related]
3. [Clinical usefulness of urinary diacetylpolyamines as novel tumor markers].
Kawakita M; Hiramatsu K; Sugimoto M; Takahashi K; Toi M
Rinsho Byori; 2004 Apr; 52(4):321-7. PubMed ID: 15164599
[TBL] [Abstract][Full Text] [Related]
4. Diacetylated derivatives of spermine and spermidine as novel promising tumor markers.
Kawakita M; Hiramatsu K
J Biochem; 2006 Mar; 139(3):315-22. PubMed ID: 16567395
[TBL] [Abstract][Full Text] [Related]
5. [Establishment of an ELISA system of N1,N12-diacetylspermine in human urine].
Matsuoka A; Sakamoto T
Rinsho Byori; 2004 Apr; 52(4):328-31. PubMed ID: 15164600
[TBL] [Abstract][Full Text] [Related]
6. Determination of amounts of polyamines excreted in urine: demonstration of N1,N8-diacetylspermidine and N1,N12-diacetylspermine as components commonly occurring in normal human urine.
Hiramatsu K; Sugimoto M; Kamei S; Hoshino M; Kinoshita K; Iwasaki K; Kawakita M
J Biochem; 1995 Jan; 117(1):107-12. PubMed ID: 7775374
[TBL] [Abstract][Full Text] [Related]
7. Determination of N¹,N¹²-diacetylspermine in urine: a novel tumor marker.
Kawakita M; Hiramatsu K; Yanagiya M; Doi Y; Kosaka M
Methods Mol Biol; 2011; 720():367-78. PubMed ID: 21318886
[TBL] [Abstract][Full Text] [Related]
8. [Urine diacetylspermine as a novel tumor marker for pancreatobiliary carcinomas].
Yamaguchi K; Nagano M; Torada N; Hamasaki N; Kawakita M; Tanaka M
Rinsho Byori; 2004 Apr; 52(4):336-9. PubMed ID: 15164602
[TBL] [Abstract][Full Text] [Related]
9. [Urinary diacetylspermine: its analysis and performance as a novel tumor marker].
Kawakita M; Hiramatsu K; Takahashi K; Yamada R; Kawaguchi M; Shinoura N; Tanaka T; Kariyone K; Tamamori Y; Sasaki Y; Mori T
Rinsho Byori; 2005 Feb; 53(2):123-9. PubMed ID: 15796045
[TBL] [Abstract][Full Text] [Related]
10. Two enzyme-linked immunosorbent assay (ELISA) systems for N1,N8-diacetylspermidine and N1,N12-diacetylspermine using monoclonal antibodies.
Hamaoki M; Hiramatsu K; Suzuki S; Nagata A; Kawakita M
J Biochem; 2002 Nov; 132(5):783-8. PubMed ID: 12417029
[TBL] [Abstract][Full Text] [Related]
11. Urine diacetylspermine as a novel tumour maker for pancreatobiliary carcinomas.
Yamaguchi K; Nakamura M; Shirahane K; Konomi H; Torata N; Hamasaki N; Kawakita M; Tanaka M
Dig Liver Dis; 2005 Mar; 37(3):190-4. PubMed ID: 15888284
[TBL] [Abstract][Full Text] [Related]
12. Significance of urinary N1,N8-diacetylspermidine and N1,N12-diacetylspermine as indicators of neoplastic diseases.
Sugimoto M; Hiramatsu K; Kamei S; Kinoshita K; Hoshino M; Iwasaki K; Kawakita M
J Cancer Res Clin Oncol; 1995; 121(5):317-9. PubMed ID: 7768972
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of urine N1, N12-diacetylspermine in patients with non-small cell lung cancer.
Kato M; Onishi H; Matsumoto K; Motoshita J; Tsuruta N; Higuchi K; Katano M
Anticancer Res; 2014 Jun; 34(6):3053-9. PubMed ID: 24922672
[TBL] [Abstract][Full Text] [Related]
14. [The significance of urine di-acetyl spermine level as a cancer marker for colorectal cancer].
Takahashi K; Hiramatsu K; Kawakita M; Mori T; Yamaguchi T; Matsumoto H; Miyamoto H; Tamamori Y
Rinsho Byori; 2004 Apr; 52(4):332-5. PubMed ID: 15164601
[TBL] [Abstract][Full Text] [Related]
15. [Serum markers in breast cancer and colorectal cancer (1997)].
Bellet D; Mlika-Cabanne N; Bedenne L; Brun B; Demeaux JL; Legrand JL; Lorimier G; Mignotte H; Ollivier JM; Piperno-Neumann S; Rinaldi Y; Rousset H; Rymer JC; Laversin S
Gynecol Obstet Fertil; 2001 Jan; 29(1):62-3. PubMed ID: 11217195
[No Abstract] [Full Text] [Related]
16. [Urinary diacetylspermine].
Kawakita M; Hiramatsu K
Nihon Rinsho; 2005 Aug; 63 Suppl 8():756-8. PubMed ID: 16149632
[No Abstract] [Full Text] [Related]
17. Excretion of N(1), N(12)-diacetylspermine in the urine of healthy individuals.
Hiramatsu K; Sakaguchi K; Fujie N; Saitoh F; Takahama E; Moriya SS; Iwasaki K; Sakaguchi M; Takahashi K; Kawaikta M
Ann Clin Biochem; 2014 Jul; 51(Pt 4):459-67. PubMed ID: 23963052
[TBL] [Abstract][Full Text] [Related]
18. [Serum markers for breast and colorectal cancers. Working group reunited by the National Health Agency for Accreditation and Evaluation (NHAAE)].
Mlika-Cabanne N; Bellet D
Gastroenterol Clin Biol; 1998 Apr; 22(4):442-57. PubMed ID: 9762275
[No Abstract] [Full Text] [Related]
19. Evaluation of urine N1,N12-Diacetylspermine as potential tumor marker for urinary bladder cancer.
Stejskal D; Humenanska V; Hanulova Z; Fiala R; Vrtal R; Solichova P; Karpisek M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):235-7. PubMed ID: 17426784
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic usefulness of N1,N8-diacetylspermidine and N1,N12-diacetylspermine in urine as novel markers of malignancy.
Hiramatsu K; Sugimoto M; Kamei S; Hoshino M; Kinoshita K; Iwasaki K; Kawakita M
J Cancer Res Clin Oncol; 1997; 123(10):539-45. PubMed ID: 9393587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
